Nitropaste for Enhanced Wound Healing in Lower Leg Surgery
This study is looking at how a medication called Nitroglycerin Ointment 2% (nitropaste) might improve wound healing after certain lower leg surgeries. These surgeries include repairs of the Achilles tendon, ankle fractures, and fractures of the shin bone (tibia) or heel bone (calcaneus). The goal is to see if nitropaste can increase blood flow to the surgical area, which is important for healing and preventing problems like infections. Researchers will measure blood flow using a special imaging system called LA-ICG before and after applying nitropaste during surgery. This study is for adults aged 18 and older who are having one of these specific lower leg surgeries. The study aims to see if nitropaste can improve immediate tissue blood flow.
- Study design
- This is an interventional study with a planned enrollment of 15 participants. It is not specified if it is randomized or blinded.
- What's involved
- Patients will have tissue perfusion measured with the LA-ICG system before and after nitropaste application during their surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints (blood flow measurements) are taken during the surgery itself.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Enhancing Wound Perfusion in High-Risk Lower Extremity Orthopaedic Surgery: A Study on Nitropaste Using Intraoperative SPY Imaging.
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Henry T Shu, MD · STUDY_DIRECTOR · Johns Hopkins University
- Babar Shafi, MD, MSPT · PRINCIPAL_INVESTIGATOR · Johns Hopkins University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Absolute fluorescence unit (AFU)Intraoperative measurement
raw fluorescence measurement
- Relative fluorescence unit (RFU)Intraoperative measurement
Will be calculated as a ratio of the mean fluorescence measure to the mean "normal" measurement. The mean "normal" measurement will be defined as the maximal signal intensity in a region outside of the wound area.
- mean incision perfusion (MIP)Intraoperative measurement
the mean fluorescence of 10 points adjacent to the incision.
- mean perfusion impairment (MPI)Intraoperative measurement
the difference between mean of each pair of points on each side of the incision.